SITABLAST-M SR 50/500
-Tablets.jpg "SITABLAST-M SR 50/500")
Sitagliptin 50 mg and Metformin HCl 500 mg (Sustained Release) Tablets
Brand :- SITABLAST-M SR 50/500
Pack Size : 10X15
Pack Type : A/A
Description :
SITABLAST-M SR 50/500 Tablets combine Sitagliptin 50 mg and Metformin Hydrochloride 500 mg (Sustained Release) to help control blood sugar levels in patients with Type 2 Diabetes. Sitagliptin enhances incretin hormone activity to improve insulin secretion, while Metformin reduces glucose production in the liver and improves insulin sensitivity. The sustained-release formulation ensures gradual drug release for prolonged glucose control when taken along with proper diet, exercise, and medical supervision.
Products
-&-Voglibose-0.3-mg-Tablets.jpg "GLYZORLLY-MV 0.3")
-&-Voglibose-0.2-mg-Tablets.jpg "GLYZORLLY-MV 0.2")
-and-Metformin-Hydrochloride-(Sustained-Release)-Tablets.jpg "GLYZORLLY-60M")
-Tablets.jpg "GLIMPZY-MP2 SR")
-Tablets-IP.jpg "GLIMPZY-MF1 500SR")
-Tablets.jpg "GLIMPZY-MF1 1000 SR")
-TABLETS.jpg "GLIMPZY-MF2/1000SR")
-Tablets.jpg "GLIMPZY-MP1 SR")
-Tablets-(450-mg-Diosmin-+-50-mg-Hesperidin).jpg "DAFLOFINE 500 mg")
-Tablets.jpg "DAPAGLYFORD-5M FORTE")
-Tablets.jpg "DAPAGLYFORD-M 10/500SR")
-Tablets.jpg "DAPAGLYFORD-10M FORTE")
-Tablets.jpg "DAPAGLYFORD-GM1 XR")
-Tablets.jpg "DAPAGLYFORD-GM2 XR")
-Tablets.jpg "DAPAGLYFORD-M 5/500SR")
-1000-mg-Tablets.jpg "Sitablast DM Forte")
-500-mg-Tablets.jpg "Sitablast DM")
-500-mg,-Glimepiride-1-mg-&-Voglibose-0.3-mg-Tablets.jpg "ORLLYMET-GV 1.3 Billyford")
-1000-mg-Tablets.jpg "Tenoliglipt-M 20/1000")
ORLLYFORD